144 related articles for article (PubMed ID: 9198103)
1. Immunohistochemical study of secretogranin II in 62 neuroendocrine tumours of the digestive tract and of the pancreas in comparison with other granins.
Le Gall F; Vallet VS; Thomas D; De Monti M; Duval J; Ramee MP
Pathol Res Pract; 1997; 193(3):179-85. PubMed ID: 9198103
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.
Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788
[TBL] [Abstract][Full Text] [Related]
3. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
Portela-Gomes GM; Grimelius L; Stridsberg M
Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
[TBL] [Abstract][Full Text] [Related]
4. Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A,B and secretogranin II.
Prommegger R; Obrist P; Ensinger C; Schwelberger HG; Wolf C; Fischer-Colbrie R; Mikuz G; Bodner E
Anticancer Res; 1998; 18(6A):3999-4002. PubMed ID: 9891437
[TBL] [Abstract][Full Text] [Related]
5. Granins and granin-related peptides in neuroendocrine tumours.
Portela-Gomes GM; Grimelius L; Wilander E; Stridsberg M
Regul Pept; 2010 Nov; 165(1):12-20. PubMed ID: 20211659
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas.
Schmid KW; Schröder S; Dockhorn-Dworniczak B; Kirchmair R; Tötsch M; Böcker W; Fischer-Colbrie R
Mod Pathol; 1994 Apr; 7(3):347-53. PubMed ID: 8058707
[TBL] [Abstract][Full Text] [Related]
7. Chromogranins A and B and secretogranin II in hormonally identified endocrine cells of the gut and the pancreas.
Buffa R; Marè P; Gini A; Salvadore M
Basic Appl Histochem; 1988; 32(4):471-84. PubMed ID: 3223865
[TBL] [Abstract][Full Text] [Related]
8. Secretoneurin in bronchopulmonary carcinoids--immunohistochemical comparison with chromogranins A and B and secretogranin II.
Tötsch M; Padberg BC; Schröder S; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
Histopathology; 1995 Apr; 26(4):357-61. PubMed ID: 7607625
[TBL] [Abstract][Full Text] [Related]
9. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas.
Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O
J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
11. Granin proteins (chromogranin A and secretogranin II C23-3 and C26-3) in the endocrine pancreas of reptiles.
Trandaburu T; Syed Ali S; Trandaburu I
Ann Anat; 1999 Sep; 181(5):489-94. PubMed ID: 10560015
[TBL] [Abstract][Full Text] [Related]
12. Widespread occurrence of chromogranins/secretogranins in the matrix of secretory granules of endocrinologically silent pituitary adenomas.
Rosa P; Bassetti M; Weiss U; Huttner WB
J Histochem Cytochem; 1992 Apr; 40(4):523-33. PubMed ID: 1552186
[TBL] [Abstract][Full Text] [Related]
13. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
14. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
15. Tumour markers in neuroendocrine tumours.
Oberg K; Janson ET; Eriksson B
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
[TBL] [Abstract][Full Text] [Related]
16. [Chromogranin A: a marker of neuroendocrine tumors].
D'Herbomez M; Gouze V
Ann Biol Clin (Paris); 2002; 60(6):641-6. PubMed ID: 12446227
[TBL] [Abstract][Full Text] [Related]
17. Expression of chromogranin A and B and secretoneurin immunoreactivity in neoplastic and nonneoplastic pancreatic alpha cells.
Schmid KW; Brink M; Freytag G; Kirchmair R; Böcker W; Fischer-Colbrie R; Heitz PU; Klöppel G
Virchows Arch; 1994; 425(2):127-32. PubMed ID: 7952497
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
[TBL] [Abstract][Full Text] [Related]
19. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
20. Granin proteins (chromogranin A and secretogranin II C23-3 and C26-3) in the intestine of amphibians.
Trandaburu T; Ali SS
Ann Anat; 1998 Dec; 180(6):523-8. PubMed ID: 9862032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]